Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer gene therapy.

Masato Yamamoto1, David T Curiel

  • 1BMR2-410, 901 19th Street South, Birmingham, AL 35294-2172, USA.

Technology in Cancer Research & Treatment
|July 21, 2005
PubMed
Summary
This summary is machine-generated.

Cancer gene therapy shows promise for unresectable cancers, but faces challenges. Ongoing research into novel genes, delivery methods, and surrogate assays aims to overcome obstacles and improve patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intranasal boosting induces variant-specific responses in SARS-CoV-2 vaccine-imprinted mice.

Nature communications·2026
Same author

AAV vectors for cancer gene therapy.

Advances in cancer research·2026
Same author

Neural stem cell delivery of oncolytic CRAd-S-pk7 immunotherapy for stage 3 ovarian cancer: Dose-regimen studies.

Molecular therapy. Oncology·2026
Same author

Long-acting interleukin-7 improves the efficacy of oncolytic viral therapy in glioblastoma.

Nature communications·2026
Same author

An intranasal adenoviral-vectored vaccine protects against highly pathogenic avian influenza H5N1 in naive and antigen-experienced animals.

Cell reports. Medicine·2026
Same author

<i>In-vivo</i>-targeted gene delivery using adenovirus-antibody site-specific covalent conjugates.

Molecular therapy. Methods & clinical development·2025

Area of Science:

  • Oncology
  • Gene Therapy
  • Cancer Research

Background:

  • Prognosis for unresectable cancers remains poor, necessitating novel therapeutic strategies.
  • Gene therapy is a promising approach, with numerous clinical trials demonstrating safety but limited efficacy.
  • Gastrointestinal cancers serve as a key example in evaluating current gene therapy research.

Purpose of the Study:

  • To provide a problem-oriented discussion on the current status of cancer gene therapy.
  • To identify and analyze obstacles hindering the full realization of cancer gene therapy.
  • To highlight ongoing research efforts and future directions in the field.

Main Methods:

  • Review of existing cancer gene therapy research, focusing on gastrointestinal cancers.

Related Experiment Videos

  • Analysis of various therapeutic agents, including cancer-selective/non-selective genes and lytic viruses.
  • Examination of diverse gene delivery strategies, encompassing viral and non-viral methods.
  • Evaluation of surrogate assays, such as soluble markers and imaging, for clinical trial enhancement.

    • Main Results:

    • Cancer gene therapy trials have established safety but have not met initial curative expectations.
    • Numerous strategies involving different genes, viruses, and delivery systems have been explored.
    • Development of surrogate assays has improved the safety and informativeness of clinical trials.
    • Current research has identified significant obstacles to effective cancer gene therapy.

    Conclusions:

    • Overcoming obstacles in cancer gene therapy requires continued research and novel concepts.
    • Efforts to refine gene delivery and therapeutic agents are crucial for clinical success.
    • Advancements in gene therapy hold potential for breakthrough treatments and cures for cancer patients.